A mass spectrometry based imaging method developed for the intracellular detection of HIV protease inhibitors
- 12 March 2009
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 23 (8) , 1183-1188
- https://doi.org/10.1002/rcm.3981
Abstract
Mass spectrometry imaging is a promising technique for measuring drugs and drug metabolites in cells and tissues. In this manuscript we describe a method for the imaging of HIV protease inhibitors. As a model system we used Mono Mac 6 cells cultured with the HIV protease inhibitors saquinavir and nelfinavir deposited on glass slides using a cytocentrifuge. A sublimation/deposition device for homogeneous matrix deposition was constructed which allows imaging of these HIV protease inhibitors at clinically relevant concentrations. Using this matrix sublimation/deposition method, glass slides containing the cytocentrifuged cells can be measured and analyzed by two types of mass spectrometry techniques, viz. matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) and MALDI Fourier transform ion cyclotron resonance (FTICR), and this makes it possible to perform imaging rapidly (MALDI-TOF) and with a very high selectivity (MALDI-FTICR). Copyright © 2009 John Wiley & Sons, Ltd.Keywords
Funding Information
- Top Institute Pharma (T4-212)
This publication has 11 references indexed in Scilit:
- Sublimation as a method of matrix application for mass spectrometric imagingJournal of the American Society for Mass Spectrometry, 2007
- Mapping pharmaceuticals in tissues using MALDI imaging mass spectrometryJournal of Pharmacological and Toxicological Methods, 2007
- MALDI-MS-based imaging of small molecules and proteins in tissuesCurrent Opinion in Chemical Biology, 2007
- Imaging of peptides in the rat brain using MALDI-FTICR mass spectrometryJournal of the American Society for Mass Spectrometry, 2007
- Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patientsJournal of Antimicrobial Chemotherapy, 2006
- Subcellular imaging mass spectrometry of brain tissueJournal of Mass Spectrometry, 2005
- The Plasma and Intracellular Steady-State Pharmacokinetics of Lopinavir/Ritonavir in HIV-1-Infected PatientsAntiviral Therapy, 2004
- Intracellular and Plasma Pharmacokinetics of Saquinavir-Ritonavir, Administered at 1,600/100 Milligrams Once Daily in Human Immunodeficiency Virus-Infected PatientsAntimicrobial Agents and Chemotherapy, 2004
- Intracellular and Plasma Pharmacokinetics of Nelfinavir and M8 in HIV-Infected Patients: Relationship with P-Glycoprotein ExpressionAntiviral Therapy, 2004
- Intracellular Accumulation of Nelfinavir and Its Relationship to P-Glycoprotein Expression and Function in HIV-Infected PatientsAntiviral Therapy, 2004